NRX Pharmaceuticals Inc

XNAS:NRXP 4:00:00 PM EDT

3.32

-0.07 (-2.06%)

7:49:22 PM EDT: $3.39 +0.07 (+2.11%)

Market Cap (Intraday)	140.78M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.33 Million
Adjusted EPS	-$0.23

See more estimates

10-Day MA	$3.38
50-Day MA	$3.56
200-Day MA	$2.90

See more pivots

NRX Pharmaceuticals Inc Stock, XNAS:NRXP

1201 Orange Street, Suite 600, Wilmington, Delaware 19801

United States of America

Phone: +1.484.254.6134

Number of Employees:

http://www.nrxpharma.com

Description

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.